Trial · NCT00153101
Trial comparisons17
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
1 to 17 of 17
Download this page as JSON| Comparison | Source |
|---|---|
| Telmisartan (TRANSCEND) vs Placebo (TRANSCEND): TRANSCEND. Composite Endpoint of Cardiovascular Death, Non-fatal Myocardial Infarction and Non-fatal Stroke | Trial comparisons |
Telmisartan (TRANSCEND) vs Placebo (TRANSCEND): TRANSCEND. Composite Endpoint of Cardiovascular Death, Non-fatal Myocardial Infarction, Non-fatal Stroke and Hospitalization for Congestive Heart Failure | Trial comparisons |
| Telmisartan (TRANSCEND) vs Placebo (TRANSCEND): TRANSCEND. Cognitive Decline | Trial comparisons |
| Telmisartan (TRANSCEND) vs Placebo (TRANSCEND): TRANSCEND. Non-fatal Myocardial Infarction | Trial comparisons |
| Telmisartan (TRANSCEND) vs Placebo (TRANSCEND): TRANSCEND. Normalisation From Micro- or Macroalbuminuria to Normoalbuminuria | Trial comparisons |
| Telmisartan (TRANSCEND) vs Placebo (TRANSCEND): TRANSCEND. Progression to ESRD | Trial comparisons |
| Telmisartan (TRANSCEND) vs Placebo (TRANSCEND): TRANSCEND. Hospitalization for Congestive Heart Failure | Trial comparisons |
| Telmisartan (TRANSCEND) vs Placebo (TRANSCEND): TRANSCEND. Combined Endpoint of Doubling Serum Creatinine, Progression to ESRD, New Microalbuminuria or New Macroalbuminuria | Trial comparisons |
| Telmisartan (TRANSCEND) vs Placebo (TRANSCEND): TRANSCEND. Cardiovascular Death | Trial comparisons |
| Telmisartan (TRANSCEND) vs Placebo (TRANSCEND): TRANSCEND. Doubling of Serum Creatinine | Trial comparisons |
| Telmisartan (TRANSCEND) vs Placebo (TRANSCEND): TRANSCEND. New Onset of Atrial Fibrillation | Trial comparisons |
| Telmisartan (TRANSCEND) vs Placebo (TRANSCEND): TRANSCEND. Non-fatal Stroke | Trial comparisons |
| Telmisartan (TRANSCEND) vs Placebo (TRANSCEND): TRANSCEND. New Macroalbuminuria | Trial comparisons |
| Telmisartan (TRANSCEND) vs Placebo (TRANSCEND): TRANSCEND. Cardiovascular Revascularization Procedure | Trial comparisons |
| Telmisartan (TRANSCEND) vs Placebo (TRANSCEND): TRANSCEND. New Microalbuminuria | Trial comparisons |
| Telmisartan (TRANSCEND) vs Placebo (TRANSCEND): TRANSCEND. Newly Diagnosed Congestive Heart Failure | Trial comparisons |
| Telmisartan (TRANSCEND) vs Placebo (TRANSCEND): TRANSCEND. Newly Diagnosed Diabetes | Trial comparisons |
trials-2026-11-12-0.4.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNone stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00153101/comparisons